← SynDRA
DELPHINIDIN
SynDRA canonical compound SYN0009145 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | EGFR | GLO1 | KDR |
| Mechanism of action | membrane permeability inhibitor |
All known targets
Mechanisms of action (all sources)
- membrane permeability inhibitor
- KDR MODULATOR
Cross-references
Synonyms
- IdB-1056
- 3,3',4',5,5',7-Hexahydroxy-2-phenylbenzopyrylium chloride
- 3,3',4',5,5',7-Hexahydroxyflavylium chloride;3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-1-benzopyrilium chloride
- Ephdine
- 2-(3,4,5-trihydroxyphenyl)chromenylium-3,5,7-triol
- Flavylium, 3,3',4',5,5',7-hexahydroxy-
- CHEBI:28436
- 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-1-benzopyrylium
- CHEBI:38701
- RefChem:910665
- DTXCID90810933
- Delfinidol chloride
- Delphinidine
- Delphinidol
- EM6MD4AEHE
- 3,3',4',5,5',7-Hexahydroxyflavylium
- liquid paraffin (drug)
- 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromenium
- Delphinidin cation
- BRN 1691007
- Delfinidol
- UNII-031A4BN94T
- 1-Benzopyryium, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-
- SCHEMBL22370
- NIOSH/LK9810000
- BDBM644036
- US11866416, Compound PBF
- BDBM50326997
- LMPK12010001
- AKOS032954895
- NCGC00592212-02
- LK98100000
- NS00074136
- ST45026079
- C05908
- 3,3',4',5,5',7-Hexahydroxyflavylium acid anion
- BRD-K79107392-003-01-4
Look up DELPHINIDIN in the interactive SynDRA portal →